Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ILOPERIDONE, with a corresponding US DMF Number 24832.
Remarkably, this DMF maintains an Active status since its submission on April 06, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2014, and payment made on March 18, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II